One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
World Hepatitis Day 2025: elimination at a critical juncture
doi : 10.1016/S2468-1253(25)00237-7
Volume 10, Issue 9, September 2025, Page 779
Unravelling the power of nocebo in symptom response to food challenge in irritable bowel syndrome
Progress in validation of treatment-response biomarkers in Crohn's disease?
Lessons learned from the BOSS trial: new directions in Barrett's oesophagus
Let's break it down: combating hepatitis stigma and discrimination
Nationwide practice change after early termination of a randomised trial of laparoscopic pancreatoduodenectomy
Effect of gluten and wheat on symptoms and behaviours in adults with irritable bowel syndrome: a single-centre, randomised, double-blind, sham-controlled crossover trial
Intraoperative fluorescence angiography with indocyanine green to prevent anastomotic leak in rectal cancer surgery (IntAct): an unblinded randomised controlled trial
Development and validation of peripheral blood DNA methylation signatures to predict response to biological therapy in adults with Crohn's disease (EPIC-CD): an epigenome-wide association study
Temporal trends in hepatitis C incidence among people tested more than once in Georgia, 2017–23: a nationwide, retrospective cohort
Primary biliary cholangitis and the narrowing gap towards optimal disease control
